Skip to main content

ROYAL BANK OF CANADA

Bank

Position in GH — Guardant Health, Inc.

CIK 1000275 TORONTO, A6

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$39,647,374
+$26,124,040 QoQ
Shares Held
264,263
+80.5% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#81
of 594 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Mar 31, 2025
CallValue
$4,260,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $3,428,309,669 across 38 Diagnostics & Research names. GH ranks #13 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $39,647,374 264,263
2026-03-31 $13,523,334 146,404
2025-12-31 $14,549,021 142,442
2025-09-30 $35,787,979 572,791
2025-06-30 $46,493,105 893,411
2025-03-31 $6,336,664 148,748
2025-03-31 $4,260,000 100,000
2024-12-31 $3,632,973 118,919
2024-09-30 $3,080,151 134,270
2024-06-30 $4,609,274 159,601
2024-03-31 $2,922,196 141,648
2023-12-31 $6,820,140 252,131
2023-09-30 $8,309,810 280,358
2023-06-30 $100,240 2,800
2023-06-30 $8,915,129 249,026
2023-03-31 $5,522,251 235,591
2022-12-31 $6,436,607 236,640
2022-09-30 $13,452,221 249,902
2022-06-30 $9,542,909 236,562
2022-03-31 $17,280,357 260,875
2021-12-31 $28,460,386 284,547
2021-09-30 $38,428,947 307,407
2021-06-30 $2,806,694 22,600
2021-06-30 $40,465,196 325,833
2021-03-31 $3,572,010 23,400
2021-03-31 $44,065,013 288,667
2020-12-31 $40,826,346 316,778
2020-09-30 $10,552,476 94,404
2020-06-30 $7,706,618 94,991
2020-03-31 $7,795,198 112,000